Keyphrases
Stroke Prevention
100%
Non-valvular Atrial Fibrillation
100%
Anticoagulants
100%
Latin American Countries
100%
Atrial Fibrillation
75%
Anticoagulant Therapy
75%
Chile
75%
All-cause Mortality
50%
Antithrombotic Therapy
50%
Mexico
50%
Antiplatelet
50%
ARGENTINA
50%
High Risk
25%
Prevention Strategies
25%
National Guidelines
25%
Patient Management
25%
Stroke Risk
25%
Antiplatelet Therapy
25%
Baseline Characteristics
25%
Clinical Trials
25%
1-year Follow-up
25%
Preventable Causes
25%
Clinical High Risk
25%
Major Bleeding
25%
Stroke Causes
25%
Vitamin K Antagonists
25%
1-year Outcome
25%
Brazil
25%
Non-vitamin K Antagonist Oral Anticoagulants
25%
Prescribing Patterns
25%
Improved Management
25%
Unique Identifier
25%
Non-valvular AF
25%
Global Rate
25%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Atrial Fibrillation
100%
Cerebrovascular Accident
100%
Anticoagulation Therapy
42%
Antiplatelet
42%
All Cause Mortality
28%
Antivitamin K
28%
Clinical Trial
14%
Bleeding
14%
Medicine and Dentistry
Apoplexy
100%
Antithrombotic
100%
Atrial Fibrillation
100%
Antiplatelet
42%
Anticoagulant Therapy
42%
All Cause Mortality
28%
Vitamin K Antagonist
28%
Clinical Trial
14%
Major Bleeding
14%
Nursing and Health Professions
Atrial Fibrillation
100%
Anticoagulant Agent
100%
Cerebrovascular Accident
100%
Anticoagulant Therapy
42%
Antivitamin K
28%
All Cause Mortality
28%
Practice Guideline
14%
Bleeding
14%